These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17397573)

  • 1. [Cutaneous necrosis in patient with chronic hepatitis].
    García-Morán S; Sáez-Royuela F; Muñoz Fernández-Lomana C
    Rev Clin Esp; 2007 Feb; 207(2):95-6. PubMed ID: 17397573
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cutaneous necrosis due to injection of interferon-alpha 2b in a patient with chronic hepatitis C].
    Castellanos González M; Pérez Carreras M; Muñoz Gómez R; Castellano Tortajada G
    Gastroenterol Hepatol; 2011 Oct; 34(8):584-5. PubMed ID: 21641684
    [No Abstract]   [Full Text] [Related]  

  • 3. [Necrotic lesion in a patient with hepatitis C virus liver disease under treatment with pegylated interferon].
    Rosel L; Blanco JR; Metota L; Oteo JA
    Enferm Infecc Microbiol Clin; 2004 Oct; 22(8):497-8. PubMed ID: 15482692
    [No Abstract]   [Full Text] [Related]  

  • 4. How to avoid discontinuation of ribavirin in combination with interferon to maintain efficacy of treatment for chronic hepatitis C patients.
    Kasahara A
    J Gastroenterol; 2004 Nov; 39(11):1125-6. PubMed ID: 15580413
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.
    Manjón-Haces JA; Vázquez-López F; Gómez-Díez S; Hidalgo-García A; Pérez-Alvarez R; Soler-Sánchez T; Pérez-Oliva N
    Acta Derm Venereol; 2001; 81(3):223. PubMed ID: 11558891
    [No Abstract]   [Full Text] [Related]  

  • 6. Face skin hyperpigmentation during pegylated interferon and ribavirin therapy.
    Yaşar B; Yaşar Ş; Güneş P
    Turk J Gastroenterol; 2015 Mar; 26(2):189-90. PubMed ID: 25835121
    [No Abstract]   [Full Text] [Related]  

  • 7. Tolerability of Peg interferon-alpha2b and Ribavirin therapy in patients with chronic hepatitis C and glucose-6-phosphate dehydrogenase deficiency.
    Demelia L; Civolani A; Murgia D; Murru A; Sorbello O; Rizzetto M
    J Hepatol; 2007 Jan; 46(1):171-3. PubMed ID: 17107736
    [No Abstract]   [Full Text] [Related]  

  • 8. Summaries for patients. Pegylated interferon with or without ribavirin for patients with hepatitis C receiving hemodialysis.
    Ann Intern Med; 2013 Dec; 159(11):I-14. PubMed ID: 24297207
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon plus ribavirin in HIV-infected patients with chronic hepatitis C.
    Pérez-Olmeda M; González J; García-Samaniego J; Arribas JR; Peña JM; Soriano V
    J Acquir Immune Defic Syndr; 1999 Nov; 22(3):308-9. PubMed ID: 10770353
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C].
    Abellán Galiana P; Pérez-Lázaro A; Aguilera Sancho-Tello V; Merino Torres JF; Berenguer Haym M; Piñón Sellés F
    Endocrinol Nutr; 2009 Mar; 56(3):136-9. PubMed ID: 19627727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune thrombocytopenia induced by PEG-IFN-alpha2b plus ribavirin in hepatitis C.
    Sagir A; Wettstein M; Heintges T; Häussinger D
    Dig Dis Sci; 2002 Mar; 47(3):562-3. PubMed ID: 11911342
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiviral therapy of patients with chronic hepatitis C with normal level of aminotransferases].
    Lopukhova NL
    Eksp Klin Gastroenterol; 2007; (4):146-52. PubMed ID: 18409502
    [No Abstract]   [Full Text] [Related]  

  • 13. Retinal vein thrombosis associated with peginterferon alpha 2b plus ribavirin in a chronic hepatitis C patient.
    Such Díaz A; Barrueco N; Esteban Alba C; Escobar Rodríguez I
    Farm Hosp; 2011; 35(2):93-4. PubMed ID: 20615736
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon alpha and ribavirin in the treatment of children with chronic hepatitis C.
    Figlerowicz M; Sluzewski W; Kowala-Piaskowska A; Mozer-Lisewska I
    Eur J Pediatr; 2004 Apr; 163(4-5):265-7. PubMed ID: 14991399
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoimmune disorders during interferon therapy in a patient with chronic hepatitis C infection: how many of them can be observed in a single patient?
    Hrstic I; Huic D; Bilusic M; Vucelic B
    J Clin Gastroenterol; 2006 Apr; 40(4):367-8. PubMed ID: 16633111
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ribavirin in combination with interferon alpha-2b in the treatment of chronic hepatitis C].
    Hillon P
    Presse Med; 2001 Feb; 30(7):335-6. PubMed ID: 11262810
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous reactions to interferon and ribavirin.
    Chamberlain AJ; Poon E
    Intern Med J; 2004 Aug; 34(8):519. PubMed ID: 15317557
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of chronic hepatitis C: interferon alpha-2b alone or in combination with ribavirin].
    Fontaine H; Pol S
    Gastroenterol Clin Biol; 1999 Apr; 23(4):541-4. PubMed ID: 10416124
    [No Abstract]   [Full Text] [Related]  

  • 19. Summaries for patients. Duration and dose of antiviral treatment for chronic hepatitis C.
    Ann Intern Med; 2004 Mar; 140(5):I67. PubMed ID: 14996694
    [No Abstract]   [Full Text] [Related]  

  • 20. Skin necrosis after injection of PEG-interferon alpha2b in an HCV-infected patient.
    Sparsa A; Loustaud-Ratti V; Alain S; Liozon E; Bédane C; Vidal E
    Acta Derm Venereol; 2004; 84(5):415-6. PubMed ID: 15503367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.